Center for Non-Invasive Brain Therapy
THE THINKING CAP®
Thirty Minute Treatment - Minimum 3 Times a week - Minimum of Six Weeks
[Clearing Neuron Pathways]
USPTO Patent # 7,771,341
USPTO Trademark # 78232716
Prototype Presentation Dates Being Set for Jan.-Feb. 2011
William Rogers, Ph.D.
Director, Behavioral Medicine
Southwest Medical Center
San Antonio, Texas
Non-Invasive & In-Office
A Significant Step Forward in the Treatment of Mental Illness
[Enhancing the Process]
The more quickly information is able to pass through specific areas of the brain such as the Frontal Lobe and the Parietal Lobe the more clearly understood that information will be. Either by nature or by accident many individuals have abnormally wired or inexplicably congested areas of the brain that are extremely important for comprehension and understanding. These cerebral abnormalities can have a strong negative impact on intelligence. Electromagnetic Brain Animation causes these less than high functioning areas to become dynamic, to be minutely shaken and vigorously moved about during treatment. The cellular structure then settles back down again. The result being a pathway that is considerably easier to navigate for information and comprehension is heightened considerably.
A unique method of using magnetic fields in conjunction with ultrasonic directional and dynamic wave patterns beamed non-invasively through the skull cap and into the brain. The is called electromagnetic brain animation. Depending on the area in need of treatment, the electromagnetic transmission hits center targets of as small as one centimeter causing the neuron structure to become dynamic, to move about vigorously and then settle back into a completely different formation than it had been in before. Years of investigation and clinical testing shows that numerous mental difficulties can be improved considerably with this new process. [Abdeen through Pascual, 1973 to 2003]
Electromagnetic brain animation (EBA) is a significant noninvasive mental illness treatment procedure having the ability to organically correct and/or rehabilitate dysfunctional neurons in the brain by causing small clusters of cellular structure to initiate dynamic interaction. This excitation is caused by weak electric currents induced in the tissue by rapidly changing magnetic fields (electromagnetic induction) disseminated from an Electromagnetic Brain Animation Generator. By doing so, brain activity can be triggered or modulated without the need for surgery or external electrodes. Repetitive electromagnetic magnetic stimulation is a powerful tool in research and diagnosis for mapping out how the brain functions, and now has been shown to be successful for noninvasive treatment of a host of mental disorders, including depression and auditory hallucinations as well as multiple others including ADD, Overanxious disorder, Pervasive Developmental Delay and Autism.. A full diagnostic description can be found at the United States Patent and Trademark Office.
In
a paradigm changing event,
Electromagnetic Brain Animation [EBA]
and
Ultrasound
[EBA/us] are both utilized for the
purpose of organically correcting either endemic or
environmental damage to the human brain. The basic
process is that a main control board induces current
consisting of changeable combinations of electricity,
magnetism, and ultrasound through the skull casing and
onto the cerebral cortex. Neuroscience has been aware
some time now which specific area or areas of the brain
cause particular mental dysfunctions. This shaft of
energy is directed at the precise part of the brain
relating to a explicit mental malfunction. By control
influence we are able to hit an area as small as one
centimeter causing the soft mucus matter to begin moving
about, to become dynamic, resulting in a depolarization
of the cell neuron structure. Depending on multiple
possible configuration, control manipulations, and
number of treatments over a specific designated time
frame; the success rate of enhancing cognitive function
above what it was previously is in an area above 60
percent. Clinical studies and research investigation
over the past five years has concluded with unequivocal
validation that EBA is a significant working instrument pertaining to alleviation of multiple mental
illness. With the pioneering introduction of ultrasound
to the equation, [EBA/us] may soon be recognized
as a seminal step forward in the history of mental
illness treatment.
One
of the primary roadblocks heretofore disallowing a
non-invasive technique to be successful is what is
referred to as the "Blood Brain Barrier".
blood'-brain' bar"rier
Pronunciation:
(blud'bran'),
A layer of tightly packed cells that make up the walls
of brain capillaries and prevent substances in the blood
from diffusing freely into the brain: passage across the
cell membranes is determined by solubility in the lipid
bilayer or recognition by a transport molecule.
Due to the ability of ultrasound to work as a guiding
"barrel" so to speak for electromagnetic induction, the
obstacle of the BBB has been overcome. Although
electromagnetic particles are too large to slip through
the 'blood brain barrier', ultrasound particles are
not. Thus, shooting the ultrasonic wave pattern through
the skull and into the brain; then follow inside with
electromagnetic current and EBA has accomplished
what was heretofore not possible.
EBA includes a method where current amplitude in the coils are controlled individually by manually and separately modulated control boxes, making it possible to influence coil emission induction without moving the coils themselves, resulting in the ability of electromagnetic emissions to transmit from different positions at the same time, making it possible to initiate conduction from different positions at different amplitudes and formulations with the outcome being multi-directional and numerous variations in dynamisms of neurons, bubbling in-out, up-down, left-right and undulating toward being engagingly fluid, thus resulting in significantly broader surface areas available for treatment which automatically mandates superior percentages of successful outcome.
EBA Basic
Principles:
Involves placing one or more electromagnetic coils in close proximity to the scalp. High-intensity current is rapidly turned on and off in the coils through the discharge of capacitors. This produces a time-varying magnetic field that lasts for about 100 to 200 microseconds. The magnetic field typically has a strength of about 2 T (40,000 times the earth's magnetic field, or about the same intensity as the static magnetic field used in clinical magnetic resonance imaging). The proximity of the brain to the time-varying magnetic field results in current flow in neural tissue. The technological advances made in the last 15 years led to the development of magnetic stimulators that produce sufficient current in brain to result in neuronal depolarization.
Neurons, due to continuing technological advances can be excited by externally applied time-varying electromagnetic fields from a number of locations at a varying amount of distances. In EBA, excitation is achieved by driving intense pulses of current I(t) through a varying number of small coils located above and on either side of the head. These coils are directed by either free standing base mounts or within a 'hat-like' device [The Thinking Cap®]. The source of activation is the electric field E induced in the tissue, obtained from Faraday’s law: The pulses of current are generated with a circuit containing a discharge capacitor connected with the coil in series by a thyristor. With the capacitor first charged to 2-4 kV, the gating of the thyristor into the conducting state will cause the discharging of the capacitor through the coil. The resulting current waveform is typically a damped sinusoidal pulse that lasts about 300 ms and has a peak value of 5-12 kA.
EBA is a method set forth where "UR/EBA" refers to ultra rapid electromagnetic brain animation of above 50 Hz, equals "high frequency EBA" or as in replication pulse rates above 1 Hz, equals "low frequency EBA" or as in replication rates below 1 Hz, and EBA/US is indicative of secondary usage of ultrasound. combined with electromagnetic brain animation and can be indicative of primary or secondary usage of ultrasound induction to target area used as a precursor cell softening instrument or as a combination guiding instrument or as follow up instrumentation used with or without EBA, indicative of resulting in a significant 65 to 85 percent success rate of noticeable improvement in neuron activity relating directly to reorganization of neuron fusion.
Several examples, not inclusive, of multiple additional significant capabilities built within 'standard EBA' beginning in 2003 are: a method of treatment set forth whereas a modality shifter adaptation from high level power source (10,000V outlet) to an extra low level power source (9V to 12V mobile battery) can be/is applicable due to an Adaptor Modality Shifter - [A mechanism (a conductive switch) allowing a variation range in all inclusive emission/conduction areas for non-invasive brain integration] A method for enhancing brain function whereas using electromagnetic brain animation, due to the "Cap" structure and formulation of all coil/conduction instrumentation residing within, variation in client head size related to treatment animation of any and all regions has no effect on clinical efficacy due to stability of instrument not found in any other "field" mechanism. And, a method for enhancing brain function of specific early development, optimum plasticity populations using electromagnetic brain animation in conjunction with a secondary complementary procedure of sonography and/or ultrasound primarily as an initiative neuron excitation prerogative which causes optimum neuron sensitivity strata acclamation for higher potential of greater success via follow-up with exclusive EBA.
[Barker to Rogers, 1985 to 2005]
"Recovered Memory and Other Assaults Upon the Mysteries of Consciousness"
Member:
We are Involved
American Association for the Advancement of Science
Institute for Ethics in Emerging Technologies
New York Academy of Sciences
Angela
Vegnente, MD,1 Antonio
Mansi, MD,1 Silvia Montella, MD,1 and Pietro Vajro
